TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression

Experimental Eye Research

Volumn 115, Issue , 2013, Pages 13-21

  Sugioka, Koji ^a   Kodama, Aya ^a   Okada, Kiyotaka ^a   Iwata, Mihoko ^a   Yoshida, Koji ^a   Kusaka, Shunji ^a   Matsumoto, Chota ^a   Kaji, Hiroshi ^a   Shimomura, Yoshikazu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell invasion; EMT; Retinal pigment epithelial cell; TGF ; UPA; UPAR

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; COLLAGEN GEL; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA2; UROKINASE;

ARTICLE; BINDING AFFINITY; BIOSENSOR; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA CELL; RETINAL PIGMENT EPITHELIAL CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

Α-SMA; Α-SMOOTH MUSCLE ACTIN; CELL INVASION; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; RETINAL PIGMENT EPITHELIAL; RETINAL PIGMENT EPITHELIAL CELL; RPE; TGF-Β; TRANSFORMING GROWTH FACTOR-BETA; UPA; UPA RECEPTOR; UPAR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; EPITHELIAL-MESENCHYMAL TRANSITION; GELS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RETINAL PIGMENT EPITHELIUM; TRANSFORMING GROWTH FACTOR BETA2; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84880977283     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.06.020     Document Type: Article

References (56)

1. Alfano D., Iaccarino I., Stoppelli M.P. Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels. J.Biol. Chem. 2006, 281:17758-17767.
2. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J.Biol. Chem. 2000, 275:36803-36810.
3. Bernstein A.M., Greenberg R.S., Taliana L., Masur S.K. Urokinase anchors uPAR to the actin cytoskeleton. Invest. Ophthalmol. Vis. Sci. 2004, 45:2967-2977.
4. Blasi F., Sidenius N. The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett. 2010, 584:1923-1930.
5. Casaroli-Marano R.P., Pagan R., Vilaro S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1999, 40:2062-2072.
6. Chandrasekar N., Mohanam S., Gujrati M., Olivero W.C., Dinh D.H., Rao J.S. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene 2003, 22:392-400.
7. Corti A., Nolli M.L., Soffientini A., Cassani G. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells. Thromb. Haemost. 1986, 56:219-224.
8. Elner S.G., Elner V.M., Kindzelskii A.L., Horino K., Davis H.R., Todd R.F., Glagov S., Petty H.R. Human RPE cell lysis of extracellular matrix: functional urokinase plasminogen activator receptor (uPAR), collagenase and elastase. Exp. Eye Res. 2003, 76:585-595.
9. Galliher A.J., Schiemann W.P. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res. 2006, 8:R42.
10. Greenburg G., Hay E.D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J.Cell Biol. 1982, 95:333-339.
11. Heldin C.H., Vanlandewijck M., Moustakas A. Regulation of EMT by TGFbeta in cancer. FEBS Lett. 2012, 586:1959-1970.
12. Hiscott P., Sheridan C., Magee R.M., Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog. Retin. Eye Res. 1999, 18:167-190.
13. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2002, 2:91-100.
14. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 2002, 62:65-74.
15. Jo M., Lester R.D., Montel V., Eastman B., Takimoto S., Gonias S.L. Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling. J.Biol. Chem. 2009, 284:22825-22833.
16. Jo M., Thomas K.S., Takimoto S., Gaultier A., Hsieh E.H., Lester R.D., Gonias S.L. Urokinase receptor primes cells to proliferate in response to epidermal growth factor. Oncogene 2007, 26:2585-2594.
17. Jobling A.I., Wan R., Gentle A., Bui B.V., McBrien N.A. Retinal and choroidal TGF-beta in the tree shrew model of myopia: isoform expression, activation and effects on function. Exp. Eye Res. 2009, 88:458-466.
18. Kang Y., Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279.
19. Kasai S., Arimura H., Nishida M., Suyama T. Thrombolytic properties of an inactive proenzyme form of human urokinase secreted from human kidney cells. Cell Struct. Funct. 1985, 10:151-159.
20. Kwak S.H., Mitra S., Bdeir K., Strassheim D., Park J.S., Kim J.Y., Idell S., Cines D., Abraham E. The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins. J.Leukoc. Biol. 2005, 78:937-945.
21. Lee S.C., Kwon O.W., Seong G.J., Kim S.H., Ahn J.E., Kay E.D. Epitheliomesenchymal transdifferentiation of cultured RPE cells. Ophthalmic Res. 2001, 33:80-86.
22. Lester R.D., Jo M., Montel V., Takimoto S., Gonias S.L. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J.Cell. Biol. 2007, 178:425-436.
23. Lin S.W., Ke F.C., Hsiao P.W., Lee P.P., Lee M.T., Hwang J.J. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Exp. Cell Res. 2007, 313:602-613.
24. Ma Z., Thomas K.S., Webb D.J., Moravec R., Salicioni A.M., Mars W.M., Gonias S.L. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J.Cell Biol. 2002, 159:1061-1070.
25. Madsen C.D., Ferraris G.M., Andolfo A., Cunningham O., Sidenius N. uPAR-induced cell adhesion and migration: vitronectin provides the key. J.Cell Biol. 2007, 177:927-939.
26. Massague J. TGFbeta in Cancer. Cell 2008, 134:215-230.
27. Matsuo O., Sakai T., Bando H., Okada K., Nakajima S., Takagi O., Izaki S. Plasminogen activator in bronchoalveolar fluid. Haemostasis 1986, 16:43-50.
28. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. Embo. J. 1997, 16:2319-2332.
29. McMahon B., Kwaan H.C. The plasminogen activator system and cancer. Pathophysiol. Haemost. Thromb. 2008, 36:184-194.
30. Miettinen P.J., Ebner R., Lopez A.R., Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J.Cell Biol. 1994, 127:2021-2036.
31. Miyazono K. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2009, 85:314-323.
32. Nguyen D.H., Hussaini I.M., Gonias S.L. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J.Biol. Chem. 1998, 273:8502-8507.
33. Nishida T., Ueda A., Fukuda M., Mishima H., Yasumoto K., Otori T. Interactions of extracellular collagen and corneal fibroblasts: morphologic and biochemical changes of rabbit corneal cells cultured in a collagen matrix. InVitro Cell Dev. Biol. 1988, 24:1009-1014.
34. Oh C.W., Hoover-Plow J., Plow E.F. The role of plasminogen in angiogenesis invivo. J.Thromb. Haemost. 2003, 1:1683-1687.
35. Okada K., Ueshima S., Kawao N., Okamoto C., Matsuo K., Akao M., Seki T., Ariga T., Tanaka M., Matsuo O. Binding of plasminogen to hepatocytes isolated from injured mouse liver and nonparenchymal-cell-dependent proliferation of hepatocytes. Blood Coagul. Fibrinolysis 2008, 19:503-511.
36. Ossowski L., Clunie G., Masucci M.T., Blasi F. Invivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J.Cell Biol. 1991, 115:1107-1112.
37. Pfeffer B.A., Flanders K.C., Guerin C.J., Danielpour D., Anderson D.H. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp. Eye Res. 1994, 59:323-333.
38. Ploug M., Ronne E., Behrendt N., Jensen A.L., Blasi F., Dano K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J.Biol. Chem. 1991, 266:1926-1933.
39. Rabbani S.A., Xing R.H. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int. J. Oncol. 1998, 12:911-920.
40. Romer J., Lund L.R., Eriksen J., Ralfkiaer E., Zeheb R., Gelehrter T.D., Dano K., Kristensen P. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J.Invest. Dermatol. 1991, 97:803-811.
41. Santibanez J.F. JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett. 2006, 580:5385-5391.
42. Santibanez J.F., Frontelo P., Iglesias M., Martinez J., Quintanilla M. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes. J.Cell Biochem. 1999, 74:61-73.
43. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
44. Siren V., Immonen I. uPA, tPA and PAI-1 mRNA expression in periretinal membranes. Curr. Eye Res. 2003, 27:261-267.
45. Siren V., Myohanen H., Vaheri A., Immonen I. Transforming growth factor beta induces urokinase receptor expression in cultured retinal pigment epithelial cells. Ophthalmic Res. 1999, 31:184-191.
46. Sturzebecher J., Vieweg H., Steinmetzer T., Schweinitz A., Stubbs M.T., Renatus M., Wikstrom P. 3-Amidinophenylalanine-based inhibitors of urokinase. Bioorg. Med. Chem. Lett. 1999, 9:3147-3152.
47. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
48. Tkachuk V.A., Plekhanova O.S., Parfyonova Y.V. Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. Can. J. Physiol. Pharmacol. 2009, 87:231-251.
49. Wang Y. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis. Med. Res. Rev. 2001, 21:146-170.
50. Warejcka D.J., Narayan M., Twining S.S. Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts. Exp. Eye Res. 2011, 93:618-627.
51. Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M.V., Chapman H.A. Regulation of integrin function by the urokinase receptor. Science 1996, 273:1551-1555.
52. Wei Y., Tang C.H., Kim Y., Robillard L., Zhang F., Kugler M.C., Chapman H.A. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells. J.Biol. Chem. 2007, 282:3929-3939.
53. Wu M., Aung H., Hirsch C.S., Toossi Z. Inhibition of Mycobacterium tuberculosis-induced signalling by transforming growth factor-beta in human mononuclear phagocytes. Scand. J. Immunol. 2012, 75:301-304.
54. Yamaguchi Y., Ishigaki T., Sano K., Miyamoto K., Nomura S., Horiuchi T. Three-dimensional invasion of epithelial-mesenchymal transition-positive human peritoneal mesothelial cells into collagen gel is promoted by the concentration gradient of fibronectin. Perit. Dial. Int. 2011, 31:477-485.
55. Yue J., Sun B., Liu G., Mulder K.M. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor. J.Cell Physiol. 2004, 199:284-292.
56. Zhang F., Tom C.C., Kugler M.C., Ching T.T., Kreidberg J.A., Wei Y., Chapman H.A. Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J.Cell Biol. 2003, 163:177-188.